AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33433595 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents who enrolled their infant
Number of subjects: 269
Study 33433595 — intervention group
Group type: COMPARATOR
Intervention: Study comprehension
Number of subjects: 269
Study 35924663 — intervention group
Group type: EXPERIMENTAL
Intervention: SC + 5 EVs (audio-visual educational videos)
Number of subjects: 195
Study 35924663 — intervention group
Group type: COMPARATOR
Intervention: Usual standard care (SC)
Number of subjects: 195
Study 33270577 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused low-intensity shock-wave therapy and androgen-stimulation therapy (MG)
Number of subjects: 42
Study 33270577 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - Androgen-stimulation therapy only
Number of subjects: 42
Study 35287133 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalizing Imagery Therapy (MIT)
Number of subjects: 46
Study 35287133 — intervention group
Group type: COMPARATOR
Intervention: Support Group (SG)
Number of subjects: 46
Study 33187543 — intervention group
Group type: EXPERIMENTAL
Intervention: XBYRT (Traditional Chinese Medicine herbal decoction)
Number of subjects: 80
Study 33187543 — intervention group
Group type: COMPARATOR
Intervention: Placebo decoction
Number of subjects: 80
Study 32356007 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA 250 mg once daily
Number of subjects: 132
Study 32356007 — intervention group
Group type: COMPARATOR
Intervention: TXA 500 mg twice daily
Number of subjects: 132
Study 33307277 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium added to inhaled corticosteroids and long-acting beta-agonists
Number of subjects: 0
Study 33307277 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium for frequent short-acting beta-agonist users
Number of subjects: 0
Study 33307277 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium for frequent exacerbators
Number of subjects: 0
Study 33307277 — intervention group
Group type: COMPARATOR
Intervention: Inhaled corticosteroids and long-acting beta-agonists (control group)
Number of subjects: 0
Study 34040056 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training (HelpMeSee Eye Surgery Simulator)
Number of subjects: 0
Study 34040056 — intervention group
Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 0
Study 35608433 — intervention group
Group type: EXPERIMENTAL
Intervention: Dezocine (0.1 mg/kg)
Number of subjects: 100
Study 35608433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (0.5 mg/kg)
Number of subjects: 100
Study 35608433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine (0.5 mg/kg) combined with Dezocine (0.1 mg/kg)
Number of subjects: 100
Study 35608433 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100
Study 33637066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and bupivacaine (ITMB) - 0.2 mg morphine and 7.5 mg bupivacaine (total 1.7 mL)
Number of subjects: 50
Study 33637066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and bupivacaine (ITMB)
Number of subjects: 50
Study 33637066 — intervention group
Group type: COMPARATOR
Intervention: Non-ITMB (control group)
Number of subjects: 50
Study 33637066 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (ITMB and non-ITMB)
Number of subjects: 50
Study 34717968 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% menthol gel (Biofreeze™)
Number of subjects: 15
Study 34717968 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 15
Study 34329606 — intervention group
Group type: COMPARATOR
Intervention: Vincristine (1.5 mg/m2) plus dexamethasone (6 mg/m2 per day for 7 days) during the second year of treatment (Control group)
Number of subjects: 5054
Study 34329606 — intervention group
Group type: EXPERIMENTAL
Intervention: No vincristine and dexamethasone pulses during the second year of treatment (Experimental group)
Number of subjects: 5054
Study 34329606 — intervention group
Group type: COMPARATOR
Intervention: Control group (Vincristine and dexamethasone)
Number of subjects: 5054
Study 34329606 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (No vincristine and dexamethasone)
Number of subjects: 5054
Study 32073152 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based prevention program (ProSAAF)
Number of subjects: 298
Study 32073152 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 298
Study 35918962 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin's biosimilar ranibizumab
Number of subjects: 202
Study 35918962 — intervention group
Group type: COMPARATOR
Intervention: Lucentis®
Number of subjects: 202
Study 33380602 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Medical Appointments (SMAs)
Number of subjects: 23
Study 33380602 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 23
Study 34282619 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementless short stem Metha
Number of subjects: 50
Study 34282619 — intervention group
Group type: COMPARATOR
Intervention: Cementless conventional straight stem Bicontact (control)
Number of subjects: 50
Study 34501792 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise program (12 weeks)
Number of subjects: 64
Study 34501792 — intervention group
Group type: COMPARATOR
Intervention: Usual lifestyles (Control Group)
Number of subjects: 64
Study 33000589 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinkeshu combined with levosimendan
Number of subjects: 100
Study 33000589 — intervention group
Group type: COMPARATOR
Intervention: Control group (levosimendan only)
Number of subjects: 100
Study 35805620 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 g per day WNS
Number of subjects: 45
Study 35805620 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.8 g per day WNS
Number of subjects: 45
Study 35805620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 33818599 — intervention group
Group type: EXPERIMENTAL
Intervention: Detention in a juvenile justice facility
Number of subjects: 1829
Study 32604235 — intervention group
Group type: EXPERIMENTAL
Intervention: Picosecond laser
Number of subjects: 14
Study 32604235 — intervention group
Group type: COMPARATOR
Intervention: Q‐switched laser
Number of subjects: 14
Study 35627475 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine supplementation
Number of subjects: 61
Study 35627475 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot supplementation
Number of subjects: 61
Study 35627475 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline supplementation
Number of subjects: 61
Study 35627475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 33736915 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of measles-mumps-rubella and one dose of varicella vaccine
Number of subjects: 5803
Study 33736915 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of measles-mumps-rubella-varicella vaccine
Number of subjects: 5803
Study 33736915 — intervention group
Group type: COMPARATOR
Intervention: Control group (two doses of measles-mumps-rubella vaccine)
Number of subjects: 5803
Study 33736915 — intervention group
Group type: EXPERIMENTAL
Intervention: Both one-dose and two-dose varicella-containing vaccines
Number of subjects: 5803
Study 33736915 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing varicella-specific antibody concentrations
Number of subjects: 5803
Study 34518906 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar injection of bupivacaine (0.1 mg/kg)
Number of subjects: 60
Study 34518906 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acetaminophen (12.5 mg/kg)
Number of subjects: 60
Study 34518906 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar injection of bupivacaine
Number of subjects: 60
Study 34518906 — intervention group
Group type: COMPARATOR
Intervention: Intravenous acetaminophen
Number of subjects: 60
Study 33418204 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorcaserin
Number of subjects: 60
Study 33418204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35711582 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐integrated Cognitive Behavior Therapy (MiCBT)
Number of subjects: 125
Study 35711582 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 125
Study 34556414 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrification with microinjection of single seminiferous tubules (VLP)
Number of subjects: 10
Study 34556414 — intervention group
Group type: COMPARATOR
Intervention: Vitrification without microinjection
Number of subjects: 10
Study 34556414 — intervention group
Group type: COMPARATOR
Intervention: Uncontrolled slow freezing (USF)
Number of subjects: 10
Study 35988289 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous blood purification treatment (hemofiltration without heparin followed by hemoadsorption)
Number of subjects: 100
Study 35988289 — intervention group
Group type: COMPARATOR
Intervention: Standard sepsis care (Control group)
Number of subjects: 100
Study 32877581 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (weekly sessions for 6 months, monthly sessions for 18 months)
Number of subjects: 803
Study 32877581 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard care from primary care team)
Number of subjects: 803
Study 35018452 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory training (up to 15 sessions)
Number of subjects: 177
Study 35018452 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 177
Study 34269550 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled intervention
Number of subjects: 0
Study 34269550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34269550 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized double-blinded studies
Number of subjects: 0
Study 33112249 — intervention group
Group type: EXPERIMENTAL
Intervention: iSpy app
Number of subjects: 44
Study 33112249 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study 35366488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pet therapy program
Number of subjects: 44
Study 35366488 — intervention group
Group type: COMPARATOR
Intervention: Standard training (control group)
Number of subjects: 44
Study 33097941 — intervention group
Group type: COMPARATOR
Intervention: Vitamin-D therapy
Number of subjects: 0
Study 33015927 — intervention group
Group type: EXPERIMENTAL
Intervention: INFOSA‐DEM intervention
Number of subjects: 0
Study 33015927 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35710510 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck isometric exercises
Number of subjects: 24
Study 35710510 — intervention group
Group type: COMPARATOR
Intervention: Conservative management without exercise
Number of subjects: 24
Study 34205413 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose for four weeks
Number of subjects: 18
Study 35013789 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon juice
Number of subjects: 10
Study 35013789 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study 35013789 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea
Number of subjects: 10
Study 33476532 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct weaning from HFOV (Observation group)
Number of subjects: 101
Study 33476532 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation after HFOV (Control group)
Number of subjects: 101
Study 33476532 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 101
Study 34343424 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 µg once daily for 6 months
Number of subjects: 30
Study 34343424 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 6 months
Number of subjects: 30
Study 35180298 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (500 mg or 1000 mg every 6 hours for 72 hours)
Number of subjects: 396
Study 35180298 — intervention group
Group type: COMPARATOR
Intervention: No acetaminophen (Control)
Number of subjects: 396
Study 34278874 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 0.5 mg
Number of subjects: 50
Study 34278874 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 50
Study 32275364 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilatational wave electroacupuncture (frequency of 2 Hz/10 Hz)
Number of subjects: 97
Study 32275364 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wave electroacupuncture (frequency of 10 Hz)
Number of subjects: 97
Study 32275364 — intervention group
Group type: COMPARATOR
Intervention: Discontinuous wave electroacupuncture (frequency of 10 Hz)
Number of subjects: 97
Study 35703814 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic repair
Number of subjects: 75
Study 35703814 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic repair
Number of subjects: 75
Study 35703814 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 75
Study 33789574 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin-meropenem combination therapy
Number of subjects: 701
Study 33789574 — intervention group
Group type: COMPARATOR
Intervention: Colistin monotherapy
Number of subjects: 701
Study 33789574 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin treatment duration
Number of subjects: 701
Study 33789574 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 701
Study 32032540 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes
Number of subjects: 5028
Study 32032540 — intervention group
Group type: COMPARATOR
Intervention: Type 2 diabetes
Number of subjects: 5028
Study 32032540 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes (first 9 years)
Number of subjects: 5028
Study 32032540 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes (subsequent years)
Number of subjects: 5028
Study 32032540 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent autoimmune diabetes (after correcting for HbA1c)
Number of subjects: 5028
Study 35299132 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainee group
Number of subjects: 258
Study 35299132 — intervention group
Group type: EXPERIMENTAL
Intervention: Current staff
Number of subjects: 258
Study 35299132 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative perceptions of morality
Number of subjects: 258
Study 33789556 — intervention group
Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938
Number of subjects: 0
Study 33789556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34057129 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive ankle dorsiflexion intervention (real)
Number of subjects: 73
Study 34057129 — intervention group
Group type: COMPARATOR
Intervention: Sham passive ankle dorsiflexion intervention (control)
Number of subjects: 73
Study 33947349 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administrated misoprostol (Cytotec®)
Number of subjects: 196
Study 33947349 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol vaginal insert (Misodel®)
Number of subjects: 196
Study 33947349 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe fear of childbirth (W‐DEQ A score ≥ 85)
Number of subjects: 196
Study 32227179 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort AD
Number of subjects: 492
Study 32227179 — intervention group
Group type: COMPARATOR
Intervention: Standard AD
Number of subjects: 492
Study 32227179 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-extending AD
Number of subjects: 492
Study 35388038 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological insight‐oriented therapy (IOT) - five 1‐h sessions
Number of subjects: 47
Study 35388038 — intervention group
Group type: COMPARATOR
Intervention: Disease related education (ED) - five 1‐h sessions
Number of subjects: 47
Study 35388038 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological insight‐oriented therapy (IOT) - first intervention
Number of subjects: 47
Study 35388038 — intervention group
Group type: COMPARATOR
Intervention: Disease related education (ED) - first intervention
Number of subjects: 47
Study 35388038 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (IOT and ED)
Number of subjects: 47
Study 32178221 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention
Number of subjects: 266
Study 32178221 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 266
Study 33727460 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar block (Group PB)
Number of subjects: 106
Study 33727460 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthesia (Group TA)
Number of subjects: 106
Study 33093056 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma with best standard of care
Number of subjects: 464
Study 33093056 — intervention group
Group type: COMPARATOR
Intervention: Best standard of care only
Number of subjects: 464
Study 34118367 — intervention group
Group type: EXPERIMENTAL
Intervention: CVs from men
Number of subjects: 0
Study 34118367 — intervention group
Group type: COMPARATOR
Intervention: CVs from women
Number of subjects: 0
Study 32706933 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week Inspired Life Program (ILP)
Number of subjects: 82
Study 32706933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study 34227246 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized Progressive Attentional Training (CPAT), n=14, 2 sessions per week for 2 months.
Number of subjects: 26
Study 34227246 — intervention group
Group type: COMPARATOR
Intervention: Active control group, n=12, matched at baseline.
Number of subjects: 26
Study 32502105 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal cannula
Number of subjects: 26
Study 32502105 — intervention group
Group type: COMPARATOR
Intervention: No nasopharyngeal cannula
Number of subjects: 26
Study 35482079 — intervention group
Group type: EXPERIMENTAL
Intervention: DM-INI
Number of subjects: 244
Study 35482079 — intervention group
Group type: EXPERIMENTAL
Intervention: Control-INI
Number of subjects: 244
Study 35482079 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall INI effect (combined DM-INI and Control-INI cohort)
Number of subjects: 244
Study 35482079 — intervention group
Group type: COMPARATOR
Intervention: INI
Number of subjects: 244
Study 34333191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention (asthma education, Fitbit, monthly group sessions, text messages, individual step goals, and study manual)
Number of subjects: 53
Study 34333191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention
Number of subjects: 53
Study 34333191 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) (asthma education plus Fitbit)
Number of subjects: 53
Study 34333191 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 53
Study 35061236 — intervention group
Group type: EXPERIMENTAL
Intervention: DS-1040 (0.6, 1.2, 2.4 or 4.8 mg)
Number of subjects: 41
Study 35061236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 34964167 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step irradiance group (40 mW/cm2 for 8 min followed by 80 mW/cm2 for 16 min)
Number of subjects: 127
Study 34964167 — intervention group
Group type: COMPARATOR
Intervention: Control group (80 mW/cm2 for 20 min)
Number of subjects: 127
Study 33533688 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) for 2.5 hours/day during NICU hospitalization
Number of subjects: 79
Study 33533688 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 79
Study 33533688 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 79
Study 32114377 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (12-15 sessions)
Number of subjects: 30
Study 32114377 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 35906640 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavones (50 mg per day for 8 weeks)
Number of subjects: 83
Study 35906640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 34801045 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist-based box system intervention
Number of subjects: 1162
Study 34801045 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional delivery
Number of subjects: 1162
Study 34801045 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge on danger signs during postnatal period
Number of subjects: 1162
Study 34801045 — intervention group
Group type: COMPARATOR
Intervention: Influence by older generations
Number of subjects: 1162
Study 35446596 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid (DRINK)
Number of subjects: 9
Study 35446596 — intervention group
Group type: EXPERIMENTAL
Intervention: Semisolid gel (GEL)
Number of subjects: 9
Study 35446596 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid jelly chew (CHEW)
Number of subjects: 9
Study 35446596 — intervention group
Group type: EXPERIMENTAL
Intervention: Coingestion (MIX)
Number of subjects: 9
Study 33764613 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal injection of plasma gel combined with fractional CO2 laser
Number of subjects: 36
Study 33764613 — intervention group
Group type: COMPARATOR
Intervention: Fractional CO2 laser alone (saline as placebo)
Number of subjects: 36
Study 32191142 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMISE breastfeeding protocol (1077BF)
Number of subjects: 3847
Study 32191142 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMISE formula-feeding protocol (1077FF)
Number of subjects: 3847
Study 32191142 — intervention group
Group type: EXPERIMENTAL
Intervention: Late Presenters
Number of subjects: 3847
Study 32191142 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study preparation and collaboration
Number of subjects: 3847
Study 35044802 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0